Abstract
Arterial hypertension is common in pediatric renal allograft recipients. While the causes are multifactorial, including chronic graft rejection, immunosuppressive therapy, and renal vascular disorders, the effect of hypertension on renal allograft function is detrimental. As in adults, if not treated early and aggressively, hypertension may lead to cardiovascular damage and graft failure. Pathophysiological changes in the arteries and kidney after renal transplantation and the impact of receptor regulation have not been studied extensively in children. For identifying children with hypertension following renal transplantation casual blood pressure measurements do not accurately reflect average arterial blood pressure and circadian blood pressure rhythm. Ambulatory 24-h blood pressure monitoring should regularly be applied in transplant patients. The purpose of this review is to analyze pathophysiological aspects of risk factors for arterial hypertension and underline the importance of regular blood pressure monitoring and early therapeutic intervention.
Similar content being viewed by others
References
Morgan H, Khan I, Hashmi A, Hebert D, McCrindle BW, Williamson Balfe J (2001) Ambulatory blood pressure monitoring after renal transplantation in children. Pediatr Nephrol 16:843–847
Kasiske BL (1987) Possible causes and consequences of hypertension in stable renal transplant patients. Transplantation 44:639–643
Luke RG (1991) Pathophysiology and treatment of post-transplant hypertension. J Am Soc Nephrol 2:S37–S44
Cheigh JS, Haschemeyer RH, Wang JC, Riggio RR, Tapia L, Stenzel KH, Rubin AL (1989) Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens 2:341–348
Baluarte HJ, Gruskin AB, Ingelfinger JR, Stablein D, Tejani A (1994) Analysis of hypertension in children post renal transplantation—a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 8:570–573
Broyer M, Gagnadoux M, Guest G (1987) Kidney transplantation in children: results of 383 grafts performed at Enfants Malades Hospital from 1973 to 1984. Adv Nephrol 16:307–334
Bartosh SM, Leverson G, Robillard D, Sollinger HW (2003) Long-term outcomes in pediatric renal transplant recipients who survive into adulthood. Transplantation 76:1195–1200
Baumgart P, Walger P, Gemen S, Eiff M von, Raidt H, Rahn KH (1991) Blood pressure elevation during the night in chronic renal failure, hemodialysis and after renal transplantation. Nephron 57:293–298
Soergel M, Maisin A, Azancot-Bénisty A, Loirat C (1992) Ambulante Blutdruckmessung bei nierentransplantierten Kindern und Jugendlichen. Z Kardiol 81 [Suppl 2]:67–70
Lingens N, Soergel M, Loirat C, Busch C, Schärer K (1995) Ambulatory blood pressure monitoring in pediatric patients treated by regular hemodialysis and peritoneal dialysis. Pediatr Nephrol 9:167–173
Tejani A (1983) Post-transplant hypertension and hypertensive encephalopathy in renal allograft recipients. Nephron 34:73–78
Querfeld U, Korten B, Naumann G, Michalk DV (1997) Medical and psychosocial rehabilitation of young adults receiving renal replacement therapy since childhood: a single-centre experience. Nephrol Dial Transplant 12:33–37
Offner G, Latta K, Hoyer PF, Baum HJ, Ehrich JH, Pichlmayr R, Brodehl J (1999) Kidney transplanted children come of age. Kidney Int 55:1509–1517
Opelz G, Wujciak T, Ritz E for the Collaborative Transplant Study (1998) Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 53:217–222
Vianello A, Mastrosimione S, Calconi G, Gatti PL, Calzavara P, Maresca MC (1993) The role of hypertension as a damaging factor for kidney grafts under cyclosporine therapy. Am J Kidney Dis 21:79–83
Mange KC, Gizman B, Joffe M, Feldman HI (2000) Arterial hypertension and renal allograft survival. JAMA 283:633–638
Sorof JM, Sullivan EK, Tejani A, Portman RJ (1999) Antihypertensive medications and renal allograft failure: a North American Pediatric Renal Transplant Cooperative Study Report. J Am Soc Nephrol 10:1324–1330
Mitsnefes MM, Omoloja A, McEnery PT (2001) Short-term pediatric renal transplant survival: blood pressure and allograft function. Pediatr Transplant 5:160–165
Mitsnefes MM, Schwartz SM, Daniels SR, Kimball TR, Khoury P, Strife CF (2001) Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr Transplant 5:279–284
Bald M (2002) Ambulatory blood pressure monitoring in children and adolescents. Current insights into a new technique. Minerva Pediatr 54:13–24
Mitsnefes MM, Portman RJ (2003) Ambulatory blood pressure monitoring in pediatric renal transplantation. Pediatr Transplant 7:86–92
Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W (1997) Oscillometric twenty-four hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 130:178–184
Wühl E, Witte K, Soergel M, Mehls O, Schaefer F, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W; German Working Group on Pediatric Hypertension (2002) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007
Hadtstein C, Wühl E, Soergel M, Witte K, Schaefer F (2004) Normative values for circadian and ultradian cardiovascular rhythms in childhood. Hypertension 43:547–554
Wühl E, Hadtstein C, Mehls O, Schaefer F; Escape Trial Group (2004) Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res 55:492–497
Calzolari A, Giordano U, Matteucci MC, Pastore E, Turchetta A, Rizzoni G, Alpert B (1998) Hypertension in young patients after renal transplantation: ambulatory blood pressure monitoring versus casual blood pressure. Am J Hypertens 11:497–501
Lingens N, Dobos E, Witte K, Busch C, Lemmer B, Klaus G, Schärer K (1997) Twenty-four-hour ambulatory blood pressure profiles in pediatric patients after renal transplantation. Pediatr Nephrol 11:23–26
Wingen AM, Fabian-Bach C, Schaefer F, Mehls O (1997) Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. Lancet 349:1117–1123
Jacobi J, Rockstroh J, John S, Schreiber M, Schlaich MP, Neumayer HH, Schmieder RE (2000) Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation. Transplantation 70:819–827
Kooman JP, Christiaans MH, Boots JM, Der Sande FM, Leunissen KM, Hooff JP van (2001) A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy. Am J Kidney Dis 37:1170–1176
Sorof JM, Goldstein SL, Brewer ED, Steiger HM, Portman RJ (2000) Use of anti-hypertensive medications and post-transplant renal allograft function in children. Pediatr Transplant 4:21–27
Troiano RP, Flegal KM (1998) Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics 101:497–504
Dietz WH (1998) Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 101:518–525
Meier-Kriesche HU, Vaghela M, Thambuganipalle R, Friedman G, Jacobs M, Kaplan B (1999) The effect of body mass index on long-term renal allograft survival. Transplantation 68:1294–1297
Moreso F, Seron D, Anunciada AI, Hueso M, Ramon JM, Fulladosa X, Gil-Vernet S, Alsina J, Grinyo JM (1998) Recipient body surface area as a predictor of post transplant renal allograft evolution. Transplantation 65:671–676
Modlin CS, Flechner SM, Goormastic M, Goldfarb DA, Papajcik D, Mastoianni B, Novick A (1997) Should obese patients lose weight before receiving a kidney transplant? Transplantation 64:599–604
Drafts HH, Anjum MR, Wynn JJ, Mulloy LL, Bowley JN, Humphries AL (1997) The impact of pre-transplant obesity on renal transplant outcomes. Clin Transplant 11:493–496
Pirsch JD, Armbrust MJ, Knechtle SJ, D’Alessandro AM, Sollinger HW, Heisey DM, Belzer FO (1995) Obesity as a risk factor following renal transplantation. Transplantation 59:631–633
Bohlin AB, Berg U (1991) Renal functional adaptation of the adult kidney following transplantation to the child. Kidney Int 39:129–134
Heffernan A, Gill D (1998) Sporting activity following kidney transplantation. Pediatr Nephrol 12:447–448
Calzolari A, Giordano U, Matteucci MC, Pastore E, Santilli A, Turchetta A, Rizzoni G (1997) Exercise tolerance and behaviour of blood pressure in children and adolescents after renal transplant. J Sports Med Phys Fitness 37:267–272
Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr (2003) Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal tranplantation. Transplantation 76:1331–1339
Gordjani N, Offner G, Hoyer PF, Brodehl J (1990) Hypertension after renal transplantation in patients treated with cyclosporine and azathioprine. Arch Dis Child 65:275–279
Hesselink DA, Hagen PM van, Balk AH, Hal PT van, Weimar W, Gelder T van (2003) Twenty five years of cyclosporine use in transplantation medicine. Ned Tijdschr Genesskd 17:955–959
Wingen AM, Feldhoff C (1999) Quality of life following renal transplantation in childhood. Zentralbl Chir 124:74–78
Hoyer PF (1995) Cyclosporine in the therapy of renal disease. Contrib Nephrol 114:111–123
Basset el-EA, Berthoux P, Cecillon S, Deprle C, Thibaudin D, De Fili JP, Alamartin E, Berthou F (2002) Hypertension after renal transplantation and polymorphisms in genes involved in essential hypertension: ACE, AGT, AT1-R, ecNOS. Clin Nephrol 57:192–200
Deray G, Hoang P, Cacoub P, Hornych A, Legrand S, Aupetit B, Zogbi F, Landault C, Baumelou A, Jacobs C (1988) Effects of ciclosporin on plasma renin activity, catecholamines and prostaglandins in patients with idiopathic uveitis. Am J Nephrol 8:298–304
Edwards BS, Hunt SA, Fowler MB, Valantine HA, Anderson LM, Lerman A (1991) Effect of ciclosporine on plasma endothelin levels in humans after cardiac transplantation. Am J Cardiol 67:782–784
Takeda M, Breyer MD, Noland TD, Homma T, Hoover RL, Inagami T, Kon V (1992) Endothelin-1 receptor antagonist: Effects on endothelin- and ciclosporine-treated mesangial cells. Kidney Int 42:1713–1719
Luke RG (1991) Mechanisms of cyclosporine-induced hypertension. Am J Hypertens 4:468–471
Siegle H, Byffle B, Patrick R (1983) Cyclosporine, the renin-angiotensin-aldosterone system and renal adverse reaction. Transplant Proc 15 [Suppl 1]:2719–2721
Nagasako SS, Koch Nogueira PC, Machado PGP, Medina Pestana JO (2003) Arterial hypertension following renal transplantation in children—a short-term study. Pediatr Nephrol 18:1270–1274
Radermacher J, Mengel M, Ellis S, Stuht S, Hiss M, Schwarz A, Eisenberger U, Burg M, Luft FC, Gwinner W, Haller H (2003) The renal arterial resistance index and renal allograft survival. N Engl J Med 349:1573–1574
Hollenbeck M, Hilbert N, Meusel F, Grabensee B (1994) Increasing sensitivity and specificity of Doppler sonographic detection of renal transplant rejection with serial investigation technique. Clin Invest 72:609–615
Wheeler DC, Steiger J (2000) Evolution and etiology of cardiovascular diseases in renal transplant recipients. Transplantation 70:SS41–SS45
Vianello A, Mastrosimone S, Calconi G, Gatti PL, Calzavara P, Maresca MC (1993) The role of hypertension as a damaging factor for kidney grafts under cyclosporine therapy. Am J Kidney Dis 21:79–83
Sanders CEJ, Curtis JJ (1995) Role of hypertension in chronic renal allograft dysfunction. Kidney Int 52 [Suppl l]:S43–S47
Luke RG, Curtis JJ, Jones P, Whelchel JD, Diethelm AG (1985) Mechanisms of posttransplant hypertension. Am J Kidney Dis 5:A79–A84
Nayir A, Bilge I, Kiliςaslan I, Ander H, Emre S and Şirin A (2001) Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 16:2041–2047
Lilien MR, Stroes ES, Op‘t Roodt J, Jongh S de, Schroder CH, Koomans HA (2003) Vascular function in children after renal transplantation. Am J Kidney Dis 41:684–691
Mc Gregor DO, Olsson C, Lynn KL (2001) Autonomic dysfunction and ambulatory blood pressure in renal transplant recipients. Transplantation 15:1277–1281
Matteucci MA, Giordano U, Calzolai A, Turchetta A, Santilli A, Tizzoni G (1999) Left ventricular hypertrophy, treadmill test, and 24-hour blood pressure in pediatric transplant patients. Kidney Int 56:1566–1570
Vécsei A, Kitzmüller E, Pichler J, Müller T, Vargha R, Ruffingshofer D, Aufricht C (2004) Auswirkungen der Blutdruckkontrolle auf Änderungen der linksventrikulären Masse bei nierentransplantierten Kindern. Nieren Hochdruckkrankheiten 33:139–140
Ogborn MR, Crocker JFS, Belitsky P, MacDonald AS, Bitter-Suermann H, Digout SC (1989) Cyclosporine A and hypertension in pediatric renal transplant recipients. Transplant Proc 21:1705–1706
Fontaine E, Barthelemy Y, Gagnadoux MF, Cukier J, Broyer M, Beurton D (1994) A review of 72 renal artery stenoses in a series of 715 kidney transplantations in children. Prog Urol 4:193–205
Fung LC, McLorie GA, Khoury AE, Churchill BM (1995) Donor aortic cuff reduces the rate of anastomotic arterial stenosis in pediatric renal transplantation. J Urol 154:909–913
Bruno S, Remuzzi G, Ruggenenti P (2004) Transplant renal artery stenosis. J Am Soc Nephrol 15:134–141
Saeed Mahmood M, Saboohi K, Osman Ali S, Bokhari AM, Frossard PM (2003) Association of the angiotensin-converting enzyme (ACE) gene G2350A dimorphism with essential hypertension. J Hum Hypertens 17:719–723
Zhu X, Chang YP, Yan D, Weder A, Cooper R, Luke A, Kan D, Chakravarti A (2003) Associations between hypertension and genes in the renin-angiotensin system. Hypertension 41:1027–1034
Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F, Bezante GP, Borgia L, Bobola N, Ravazzolo R, Sacci G, Deferrari G (1996) The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol 7:2550–2558
Kikuya M, Sugimoto K, Katsuya T, Suzuki M, Sato T, Funahashi J, Katoh R, Kazama I, Michimata M, Araki T, Hozawa A, Tsuji I, Ogihara T, Yanagisawa T, Imai Y, Matsubara M (2003) A/C 1166 gene polymorphism of the angiotensin II type 1 receptor (AT1) and ambulatory blood pressure: the Ohasama study. Hypertens Res 26:141–145
Schmidt S, Beige J, Walla-Friedel M, Michel MC, Sharma AM, Ritz E (1997) A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens 15:1385–1388
Büscher R, Eilmes KJ, Hoyer PF (2003) Renin-angiotensin gene and β2-adrenergic receptor gene polymorphism in children with essential hypertension. J Am Soc Nephrol 14:524A
Filler G, Yang F, Martin A, Stolpe J, Neumayer HH, Hocher B (2001) Renin angiotensin system gene polymorphisms in pediatric renal transplant recipients. Pediatr Transplant 5:166–173
Prasad GV, Pinnaduwage D, Parkes RK, Midgley J, Balfe JW, Hegel RA, Bull SB, Cole EH, Logan AG (2003) Angiotensinogen M235T genotype predicts progression in chronic renal allograft dysfunction. Transplantation 27:209–216
Basset el EA, Berthoux P, Cecillon S, Deprle C, Thibaudin D, Fili JP de, Alamartin E, Berthou F (2002) Hypertension after renal transplantation and polymorphism genes involved in essential hypertension: ACE, AGT, AT1R ecNOS. Clin Nephrol 57:192–200
Acknowledgement
Our work was supported by Forschungsunterstützungskreis Kindernephrologie Essen e.V.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Büscher, R., Vester, U., Wingen, AM. et al. Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients. Pediatr Nephrol 19, 1202–1211 (2004). https://doi.org/10.1007/s00467-004-1601-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-004-1601-2